Inflammasome-Mediated Autoinflammatory Disorders

References

• . McDermott MF, Aksentijevich I. The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol. 2002;2(6):511–516
   Google Scholar
• . McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3(8):e297
   PubMed Web of Science ®Google Scholar
• . Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216
   PubMed Web of Science ®Google Scholar
• . Jones JD, Dangl JL. The plant immune system. Nature. 2006;444(7117):323–329
   PubMed Web of Science ®Google Scholar
• . Ye Z, Ting JP. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol. 2008;20(1):3–9
   Google Scholar
• . Ting JP, Lovering RC, Alnemri ES, . The NLR gene family: a standard nomenclature. Immunity. 2008;28(3):285–287
   PubMed Web of Science ®Google Scholar
• . Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229–265
   PubMed Web of Science ®Google Scholar
• . Hornung V, Latz E. Intracellular DNA recognition. Nat Rev Immunol. 2010;10(2):123–130
   PubMed Web of Science ®Google Scholar
• . Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschop J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20(3):319–325
   PubMed Web of Science ®Google Scholar
• . Allen IC, Scull MA, Moore CB, . The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30(4):556–565
   PubMed Web of Science ®Google Scholar
• . Cassel SL, Joly S, Sutterwala FS. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol. 2009;21(4):194–198
   PubMed Web of Science ®Google Scholar
• . Aganna E, Martinon F, Hawkins PN, . Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 2002;46(9):2445–2452
   PubMed Web of Science ®Google Scholar
• . Aksentijevich I, Nowak M, Mallah M, . De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46(12):3340–3348
   PubMed Web of Science ®Google Scholar
• . Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301–305
   PubMed Web of Science ®Google Scholar
• . Aksentijevich I, Putnam DP, Remmers EF, . The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56(4):1273–1285
   PubMed Web of Science ®Google Scholar
• . Dodé C, Le Dú N, Cuisset L, . New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet. 2002;70(6):1498–1506
   Google Scholar
• . Feldmann J, Prieur AM, Quartier P, . Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002;71(1):198–203
   PubMed Web of Science ®Google Scholar
• . Dowds TA, Masumoto J, Zhu L, Inohara N, Núnez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem. 2004;279(21):21924–21928
   Google Scholar
• . Goldbach-Mansky R, Kastner DL. Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol. 2009;124(6):1141–1149
   PubMed Web of Science ®Google Scholar
• . Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol. 2008;33(1):1–9
   Google Scholar
• . Goldbach-Mansky R, Dailey NJ, Canna SW, . Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006;355(6):581–592
   PubMed Web of Science ®Google Scholar
• . Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med. 2003;348(25):2583–2584
   PubMed Web of Science ®Google Scholar
• . Hoffman HM. Therapy of autoinflammatory syndromes. J Allergy Clin Immunol. 2009;124(6):1129–1138
   PubMed Web of Science ®Google Scholar
• . Goldbach-Mansky R, Shroff SD, Wilson M, . A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum. 2008;58(8):2432–2442
   PubMed Web of Science ®Google Scholar
• . Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, . Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360(23):2416–2425
   PubMed Web of Science ®Google Scholar
• . Johnson SA, Kile RL, Kooyman DJ, Whitehouse HS, Brod JS. Comparison of effects of soaps and synthetic detergents on hands of housewives; clinical method. AMA Arch Derm Syphilol. 1953;68(6):643–650
   Google Scholar
• . Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001;108(4):615–620
   PubMed Web of Science ®Google Scholar
• . Hoffman HM, Rosengren S, Boyle DL, . Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364(9447):1779–1785
   PubMed Web of Science ®Google Scholar
• . Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredofamilial syndrome. Q J Med. 1962;31:235–248
   PubMedGoogle Scholar
• . Haas N, Kuster W, Zuberbier T, Henz BM. Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol. 2004;151(1):99–104
   Google Scholar
• . Prieur AM, Griscelli C. Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr. 1981;99(1):79–83
   Google Scholar
• . Hashkes PJ, Lovell DJ. Recognition of infantile-onset multisystem inflammatory disease as a unique entity. J Pediatr. 1997;130(4):513–515
   Google Scholar
• . Prieur AM. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol. 2001;19(1):103–106
   PubMed Web of Science ®Google Scholar
• . Hill SC, Namde M, Dwyer A, Poznanski A, Canna S, Goldbach-Mansky R. Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA). Pediatr Radiol. 2007;37(2):145–152
   PubMed Web of Science ®Google Scholar
• . Prieur AM, Griscelli C, Lampert F, . A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl. 1987;66:57–68
   PubMedGoogle Scholar
• . Richette P, Bardin T. Gout. Lancet. 2010;375(9711):318–328
   PubMed Web of Science ®Google Scholar
• . Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237–241
   PubMed Web of Science ®Google Scholar
• . McGonagle D, Tan AL, Madden J, Emery P, McDermott MF. Successful treatment of resistant pseudogout with anakinra. Arthritis Rheum. 2008;58(2):631–633
   Google Scholar
• . So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther. 2007;9(2):R28
   PubMed Web of Science ®Google Scholar
• . Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157(5 pt 1):1666–1680
   PubMed Web of Science ®Google Scholar
• . Cassel SL, Eisenbarth SC, Iyer SS, . The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A. 2008;105(26):9035–9040
   PubMed Web of Science ®Google Scholar
• . Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876):674–677
   PubMed Web of Science ®Google Scholar
• . Hornung V, Bauernfeind F, Halle A, . Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9(8):847–856
   PubMed Web of Science ®Google Scholar
• . Maedler K, Sergeev P, Ris F, . Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110(6):851–860
   PubMed Web of Science ®Google Scholar
• . Larsen CM, Faulenbach M, Vaag A, . Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356(15):1517–1526
   PubMed Web of Science ®Google Scholar
• . Lamkanfi M, Mueller JL, Vitari AC, . Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol. 2009;187(1):61–70
   PubMed Web of Science ®Google Scholar
• . Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140
   PubMed Web of Science ®Google Scholar
• . Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol. 2009;27:621–668
   PubMed Web of Science ®Google Scholar
• . Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227–253
   PubMed Web of Science ®Google Scholar
• . Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90(4):797–807
   PubMed Web of Science ®Google Scholar
• . Richards N, Schaner P, Diaz A, . Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem. 2001;276(42):39320–39329
   PubMed Web of Science ®Google Scholar
• . Yu JW, Wu J, Zhang Z, . Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ. 2006;13(2):236–249
   PubMed Web of Science ®Google Scholar
• . Chae JJ, Wood G, Masters SL, . The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A. 2006;103(26):9982–9987
   PubMed Web of Science ®Google Scholar
• . Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72(7):611–615
   Web of Science ®Google Scholar
• . Wise CA, Gillum JD, Seidman CE, . Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet. 2002;11(8):961–969
   PubMed Web of Science ®Google Scholar
• . Shoham NG, Centola M, Mansfield E, . Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A. 2003;100(23):13501–13506
   PubMed Web of Science ®Google Scholar
• . Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol. 2009;161(5):1199–1201
   PubMed Web of Science ®Google Scholar
• . Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology (Oxford). 2005;44(3):406–408
   PubMed Web of Science ®Google Scholar
• . Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore). 1994;73(3):133–144
   Google Scholar
• . Houten SM, Kuis W, Duran M, . Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet. 1999;22(2):175–177
   PubMed Web of Science ®Google Scholar
• . Kuijk LM, Beekman JM, Koster J, Waterham HR, Frenkel J, Coffer PJ. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood. 2008;112(9):3563–3573
   Google Scholar
• . Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med. 2005;63(7):260–264
   Google Scholar
• . Cailliez M, Garaix F, Rousset-Rouviere C, . Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis. 2006;29(6):763
   Google Scholar
• . de Koning HD, Bodar EJ, van der Meer JW, Simon A; Schnitzler Syndrome Study Group. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum. 2007;37(3):137–148
   PubMed Web of Science ®Google Scholar
• . Besada E, Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol. 2010;29(5):567–571
   PubMed Web of Science ®Google Scholar
• . Pizzirani C, Falzoni S, Govoni M, . Dysfunctional inflammasome in Schnitzler's syndrome. Rheumatology (Oxford). 2009;48(1):1304–1308
   Google Scholar
• . Jin Y, Mailloux CM, Gowan K, . NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356(12):1216–1225
   PubMed Web of Science ®Google Scholar
• . Hugot JP, Chamaillard M, Zouali H, . Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599–603
   PubMed Web of Science ®Google Scholar
• . Ogura Y, Bonen DK, Inohara N, . A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603–606
   PubMed Web of Science ®Google Scholar
• . Lesage S, Zouali H, Cézard JP, ; EPWG-IBD Group; EPIMAD Group; GETAID Group. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70(4):845–857
   PubMed Web of Science ®Google Scholar
• . Hugot JP. CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci. 2006;1072:9–18
   PubMed Web of Science ®Google Scholar
• . Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006;12(7):641–650
   PubMed Web of Science ®Google Scholar
• . Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107(5):689–693
   PubMed Web of Science ®Google Scholar
• . Miceli-Richard C, Lesage S, Rybojad M, . CARD15 mutations in Blau syndrome. Nat Genet. 2001;29(1):19–20
   PubMed Web of Science ®Google Scholar
• . Rahman P, Bartlett S, Siannis F, . CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet. 2003;73(3):677–681
   Google Scholar
• . Giardina E, Novelli G, Costanzo A, . Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J Invest Dermatol. 2004;122(5):1106–1107
   Google Scholar
• . Jenisch S, Hampe J, Elder JT, . CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association. Arch Dermatol Res. 2006;297(9):409–411
   Google Scholar
• . Lascorz J, Burkhardt H, Huffmeier U, . Lack of genetic association of the three more common polymorphisms of CARD1 5 with psoriatic arthritis and psoriasis in a German cohort. Ann Rheum Dis. 2005;64(6):951–954
   Google Scholar
• . Lich JD, Ting JP. Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions. Microbes Infect. 2007;9(5):672–676
   Google Scholar
• . Jéru I, Duquesnoy P, Fernandes-Alnemri T, . Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci U S A. 2008;105(5):1614–1619
   PubMed Web of Science ®Google Scholar